Literature DB >> 24667219

Cannabinoid hyperemesis syndrome: a case report and review of pathophysiology.

Corina L Iacopetti1, Clifford D Packer2.   

Abstract

Cannabis is the most widely used illicit drug in the United States, with lifetime prevalence of use estimated at 42% to 46%. The antiemetic properties of cannabis are well-known by the medical community and the general public; however, less well-recognized is the paradoxical potential for certain chronic users to develop hyperemesis. We describe in this case a patient with prior extensive work-up for nausea and vomiting and previous diagnosis of cyclic vomiting syndrome who presented with characteristic features of cannabinoid hyperemesis syndrome. We review the current literature for this condition and highlight potential mechanisms for its pathogenesis.
© 2014 Marshfield Clinic.

Entities:  

Keywords:  Cannabis; Cyclic vomiting; Hyperemesis; Marijuana

Mesh:

Substances:

Year:  2014        PMID: 24667219      PMCID: PMC4453416          DOI: 10.3121/cmr.2013.1179

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  12 in total

1.  Cannabinoid hyperemesis: a case series of 98 patients.

Authors:  Douglas A Simonetto; Amy S Oxentenko; Margot L Herman; Jason H Szostek
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

Review 2.  Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm.

Authors:  Erik A Wallace; Sarah E Andrews; Chad L Garmany; Martina J Jelley
Journal:  South Med J       Date:  2011-09       Impact factor: 0.954

3.  Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.

Authors:  S A Varvel; D T Bridgen; Q Tao; B F Thomas; B R Martin; A H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2005-04-14       Impact factor: 4.030

Review 4.  Cannabinoid hyperemesis syndrome.

Authors:  Jonathan A Galli; Ronald Andari Sawaya; Frank K Friedenberg
Journal:  Curr Drug Abuse Rev       Date:  2011-12

5.  Modulation of delta9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat.

Authors:  D T Malone; D A Taylor
Journal:  Br J Pharmacol       Date:  1998-08       Impact factor: 8.739

6.  Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse.

Authors:  J H Allen; G M de Moore; R Heddle; J C Twartz
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

7.  Behavioral and temperature effects of delta 9-tetrahydrocannabinol in human-relevant doses in rats.

Authors:  Michael S Smirnov; Eugene A Kiyatkin
Journal:  Brain Res       Date:  2008-06-26       Impact factor: 3.252

8.  Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew).

Authors:  Linda A Parker; Magdalena Kwiatkowska; Page Burton; Raphael Mechoulam
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

9.  Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint.

Authors:  Stefan W Toennes; Johannes G Ramaekers; Eef L Theunissen; Manfred R Moeller; Gerold F Kauert
Journal:  J Anal Toxicol       Date:  2008-09       Impact factor: 3.367

10.  Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys.

Authors:  Louisa Degenhardt; Wai-Tat Chiu; Nancy Sampson; Ronald C Kessler; James C Anthony; Matthias Angermeyer; Ronny Bruffaerts; Giovanni de Girolamo; Oye Gureje; Yueqin Huang; Aimee Karam; Stanislav Kostyuchenko; Jean Pierre Lepine; Maria Elena Medina Mora; Yehuda Neumark; J Hans Ormel; Alejandra Pinto-Meza; José Posada-Villa; Dan J Stein; Tadashi Takeshima; J Elisabeth Wells
Journal:  PLoS Med       Date:  2008-07-01       Impact factor: 11.069

View more
  10 in total

1.  Management of Pediatric Cannabinoid Hyperemesis Syndrome: A Review.

Authors:  Justin P Reinert; O'Neill Niyamugabo; Kiersi S Harmon; Norman E Fenn
Journal:  J Pediatr Pharmacol Ther       Date:  2021-05-19

2.  Cannabinoid Hyperemesis Syndrome Associated With Compulsive Showering and Acute Kidney Injury.

Authors:  Priya Srihari; Mengyang Liu; Steven Punzell; Shady S Shebak; William S Rea
Journal:  Prim Care Companion CNS Disord       Date:  2016-02-25

Review 3.  Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Authors:  Cecilia J Sorensen; Kristen DeSanto; Laura Borgelt; Kristina T Phillips; Andrew A Monte
Journal:  J Med Toxicol       Date:  2016-12-20

4.  Cannabinoid hyperemesis syndrome and the onset of a manic episode.

Authors:  Phillip Gregoire; Michael Tau; David Robertson
Journal:  BMJ Case Rep       Date:  2016-04-27

5.  Cannabinoid hyperemesis syndrome.

Authors:  Jai D Parekh; Susan E Wozniak; Kamran Khan; Sudhir K Dutta
Journal:  BMJ Case Rep       Date:  2016-01-20

6.  Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome.

Authors:  Thangam Venkatesan; David J Levinthal; B U K Li; Sally E Tarbell; Kathleen A Adams; Robert M Issenman; Irene Sarosiek; Safwan S Jaradeh; Ravi N Sharaf; Shahnaz Sultan; Christopher D Stave; Andrew A Monte; William L Hasler
Journal:  Neurogastroenterol Motil       Date:  2019-06       Impact factor: 3.598

7.  Review of Medicinal Use of Cannabis Derivatives and the Societal Impact of Legalization.

Authors:  Akshat Malik; Khuzema Saifuddin Fatehi; Nandini N Menon; Pankaj Chaturvedi
Journal:  Indian J Palliat Care       Date:  2020-08-29

Review 8.  Cyclic vomiting syndrome: a case series and review of the literature.

Authors:  Jessica Shearer; Pavit Luthra; Alexander C Ford
Journal:  Frontline Gastroenterol       Date:  2016-05-27

Review 9.  [Cannabinoid hyperemesis as a differential diagnosis of nausea and vomiting in the emergency department].

Authors:  F Korn; S Hammerich; A Gries
Journal:  Anaesthesist       Date:  2021-02       Impact factor: 1.041

10.  The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations.

Authors:  Samuel E Vaughn; Jeffrey R Strawn; Ethan A Poweleit; Mayur Sarangdhar; Laura B Ramsey
Journal:  J Pers Med       Date:  2021-06-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.